A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.
about
Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and managementRecapitulation of acquired immuno deficiency syndrome associated Kaposi's sarcomaReduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and preventionKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversionUpdate on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.Antitumour effects of antiretroviral therapy.A case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation.Fifty years of multicentric Castleman's disease.Paclitaxel for AIDS-associated Kaposi's sarcoma.Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settingsEffects of different types of exercise on body composition and fat distribution in HIV-infected patients: a brief review.AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapyCancer prevention in HIV-infected populations.The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men.Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology.Cancer in cohort of HIV-infected population: prevalence and clinical characteristics.Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.Combination antiretroviral therapy and cancer risk.Ongoing change in the treatment of HIV-associated malignancies in the HAART era.Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trialAssessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome.Kaposi's sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009.A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.A Case of Ocular Kaposi's Sarcoma Successfully Treated with Highly Active Antiretroviral Therapy (HAART) Combined with Docetaxel
P2860
Q22251070-22524EF9-F2AE-4EC8-8DB3-E2CAE4421187Q28080182-A3B5F1A0-E76A-4643-97D8-E912DBA8A42DQ33610926-08DBAAFC-2716-4E29-A6B8-A35EBA0EEC60Q33638209-5C5FFB7A-6740-42FE-BFEC-FBBF020E62EDQ33642284-E2777AAD-C4A0-48CB-B049-4A86E28BB239Q33761091-0E7F7B82-36FE-46C0-BF1C-F9FEA0B75AC1Q33888845-61E11B10-4113-41A8-A398-E15ABE454612Q34168712-FC16E034-083B-4B8A-A459-2B4E14153BAEQ34587349-C5227743-0BA3-44A2-814E-CB51C3784F4AQ34952990-7080F1D7-80B0-49E5-B708-52AC203489D7Q35715660-08F9E17B-5AFC-43A9-9C59-F559A54DFD7BQ35934144-D74A9D8F-DDC6-43F8-A96D-A25A88F08A66Q35969629-6CCE8AB3-4606-4A2A-A400-E3D0895E14DAQ36069611-3E8C6D54-86D9-469E-B80B-FEC98C5B2C68Q36118375-748960DD-CA83-468A-AB22-38F41CF61D1EQ36162341-EF540886-47F1-47F7-B980-2933F427DEA4Q36176266-65260E51-6BBF-4A5D-8084-53464C86A84FQ36268446-EB3A1A9D-2E35-4F29-9B5F-ADFFB72AC69BQ36614066-78E0D2B1-C9AD-404B-9BB3-BC3525ECCA81Q36680086-3D5F9CC1-0698-4A1F-883F-3130DEF2EF65Q36746821-5C974E0C-FA4F-4C1D-8EBD-96B6145E1420Q36957884-328A2BEE-729D-4272-BC78-E35D53D1CC58Q37200835-ACC8053A-AABE-4B82-875F-BA367B2EAB21Q37287937-EDCBCE3A-0DCA-4A37-B6A8-132773DF7B95Q37763574-E6C36984-7FAB-422C-9015-2687B8CDCA89Q37888397-CF3EBF45-D4C0-49D5-BC43-AFF5538C163CQ38081246-A3823666-D859-4F39-8D37-55AFEC23EB96Q38868936-11EAD795-1BB9-4AAF-81CE-EAEE5CA6A0C6Q38984209-E387F5F2-42B5-4D8B-B64C-810CD5A26EBDQ39207881-F9825FDF-4BFF-46AE-8713-38E34C9C3308Q39230042-388AC7BB-F362-49FC-B336-4960F6843D99Q39324863-52D29C49-108E-4059-8476-297DA5B15251Q41956982-9034B2E7-0A13-4144-85B5-B13285DE0563Q42281909-B6F526B3-AFE3-4EA2-914B-58AD9F2A4D13Q46895968-513A99C2-0EA5-4B46-B3D5-C9D98244A1F2Q53374076-F94F1BB0-3CE8-4E21-821C-417437457BD7Q53608089-DD9E9741-7FB1-40A7-B2B8-CB687C1A5068Q58754121-2669AF10-EA15-4BCF-9287-D7219ACE0F7E
P2860
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@ast
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@en
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@nl
type
label
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@ast
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@en
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@nl
prefLabel
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@ast
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@en
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@nl
P2093
P1433
P1476
A comparison of regimens based ...... n preventing Kaposi's sarcoma.
@en
P2093
Brian Gazzard
Justin Stebbing
Mark Bower
Mark Nelson
Simon Portsmouth
Sundhiya Mandalia
P304
P356
10.1097/00002030-200307250-00001
P407
P577
2003-07-01T00:00:00Z